(AEIS) Advanced Energy Industries - Overview
Stock: Power Supplies, Plasma Generators, Sensors, Test Equipment, Repair Services
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.29% |
| Yield on Cost 5y | 0.35% |
| Yield CAGR 5y | 0.00% |
| Payout Consistency | 96.7% |
| Payout Ratio | 9.0% |
| Risk 5d forecast | |
|---|---|
| Volatility | 46.9% |
| Relative Tail Risk | -7.84% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.86 |
| Alpha | 113.82 |
| Character TTM | |
|---|---|
| Beta | 1.957 |
| Beta Downside | 1.861 |
| Drawdowns 3y | |
|---|---|
| Max DD | 39.87% |
| CAGR/Max DD | 1.10 |
Description: AEIS Advanced Energy Industries January 08, 2026
Advanced Energy Industries (AEIS) designs and manufactures precision power conversion, measurement, and control products that serve semiconductor fabrication, industrial production, medical, data-center, networking, and telecommunications equipment. Its portfolio includes plasma power systems for dry-etch and deposition, high- and low-voltage supplies for a broad range of equipment, and sensing/instrumentation solutions for power and temperature calibration, complemented by aftermarket services such as refurbishments, repairs, and upgrades.
In FY 2023 the company generated roughly $1.3 billion in revenue, up about 12 % year-over-year, with an operating margin near 14 %, reflecting strong pricing power in a market where semiconductor fab spending is projected to grow ~6 % CAGR through 2029. AEIS benefits from the secular shift toward advanced nodes and the “China-plus-one” strategy, which is driving new fab construction in the United States and Europe-key tailwinds for its plasma and power-supply product lines. The firm’s R&D spend, roughly 8 % of revenue, is focused on expanding its high-efficiency, low-emissions power solutions, positioning it to capture growth in both mature and emerging process technologies.
For a deeper quantitative assessment, you may find ValueRay’s analyst tools useful.
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income: 145.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 2.83 > 1.0 |
| NWC/Revenue: 65.87% < 20% (prev 71.62%; Δ -5.75% < -1%) |
| CFO/TA 0.10 > 3% & CFO 233.6m > Net Income 145.0m |
| Net Debt (-75.8m) to EBITDA (227.1m): -0.33 < 3 |
| Current Ratio: 4.10 > 1.5 & < 3 |
| Outstanding Shares: last quarter (38.5m) vs 12m ago 2.58% < -2% |
| Gross Margin: 37.60% > 18% (prev 0.35%; Δ 3725 % > 0.5%) |
| Asset Turnover: 74.49% > 50% (prev 67.12%; Δ 7.37% > 0%) |
| Interest Coverage Ratio: 10.39 > 6 (EBITDA TTM 227.1m / Interest Expense TTM 15.7m) |
Altman Z'' 6.00
| A: 0.47 (Total Current Assets 1.50b - Total Current Liabilities 366.5m) / Total Assets 2.44b |
| B: 0.45 (Retained Earnings 1.09b / Total Assets 2.44b) |
| C: 0.07 (EBIT TTM 163.6m / Avg Total Assets 2.32b) |
| D: 0.96 (Book Value of Equity 1.09b / Total Liabilities 1.13b) |
| Altman-Z'' Score: 6.00 = AAA |
Beneish M -3.06
| DSRI: 0.99 (Receivables 299.5m/259.4m, Revenue 1.72b/1.47b) |
| GMI: 0.94 (GM 37.60% / 35.16%) |
| AQI: 0.92 (AQ_t 0.24 / AQ_t-1 0.26) |
| SGI: 1.17 (Revenue 1.72b / 1.47b) |
| TATA: -0.04 (NI 145.0m - CFO 233.6m) / TA 2.44b) |
| Beneish M-Score: -3.06 (Cap -4..+1) = AA |
What is the price of AEIS shares?
Over the past week, the price has changed by +7.01%, over one month by +18.96%, over three months by +24.73% and over the past year by +142.29%.
Is AEIS a buy, sell or hold?
- StrongBuy: 6
- Buy: 1
- Hold: 4
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the AEIS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 263 | -3.8% |
| Analysts Target Price | 263 | -3.8% |
| ValueRay Target Price | 364.2 | 33.3% |
AEIS Fundamental Data Overview February 07, 2026
P/E Forward = 43.8596
P/S = 5.6381
P/B = 7.4327
P/EG = 0.41
Revenue TTM = 1.72b USD
EBIT TTM = 163.6m USD
EBITDA TTM = 227.1m USD
Long Term Debt = 566.8m USD (from longTermDebt, last quarter)
Short Term Debt = 17.9m USD (from shortTermDebt, last quarter)
Debt = 682.8m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -75.8m USD (from netDebt column, last quarter)
Enterprise Value = 9.65b USD (9.72b + Debt 682.8m - CCE 758.8m)
Interest Coverage Ratio = 10.39 (Ebit TTM 163.6m / Interest Expense TTM 15.7m)
EV/FCF = 63.92x (Enterprise Value 9.65b / FCF TTM 150.9m)
FCF Yield = 1.56% (FCF TTM 150.9m / Enterprise Value 9.65b)
FCF Margin = 8.75% (FCF TTM 150.9m / Revenue TTM 1.72b)
Net Margin = 8.41% (Net Income TTM 145.0m / Revenue TTM 1.72b)
Gross Margin = 37.60% ((Revenue TTM 1.72b - Cost of Revenue TTM 1.08b) / Revenue TTM)
Gross Margin QoQ = 38.83% (prev 37.01%)
Tobins Q-Ratio = 3.96 (Enterprise Value 9.65b / Total Assets 2.44b)
Interest Expense / Debt = 0.62% (Interest Expense 4.20m / Debt 682.8m)
Taxrate = 11.28% (5.90m / 52.3m)
NOPAT = 145.2m (EBIT 163.6m * (1 - 11.28%))
Current Ratio = 4.10 (Total Current Assets 1.50b / Total Current Liabilities 366.5m)
Debt / Equity = 0.52 (Debt 682.8m / totalStockholderEquity, last quarter 1.31b)
Debt / EBITDA = -0.33 (Net Debt -75.8m / EBITDA 227.1m)
Debt / FCF = -0.50 (Net Debt -75.8m / FCF TTM 150.9m)
Total Stockholder Equity = 1.25b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.26% (Net Income 145.0m / Total Assets 2.44b)
RoE = 11.60% (Net Income TTM 145.0m / Total Stockholder Equity 1.25b)
RoCE = 9.01% (EBIT 163.6m / Capital Employed (Equity 1.25b + L.T.Debt 566.8m))
RoIC = 8.00% (NOPAT 145.2m / Invested Capital 1.82b)
WACC = 12.30% (E(9.72b)/V(10.41b) * Re(13.12%) + D(682.8m)/V(10.41b) * Rd(0.62%) * (1-Tc(0.11)))
Discount Rate = 13.12% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 1.21%
[DCF Debug] Terminal Value 66.11% ; FCFF base≈120.1m ; Y1≈133.4m ; Y5≈174.2m
Fair Price DCF = 44.83 (EV 1.62b - Net Debt -75.8m = Equity 1.69b / Shares 37.7m; r=12.30% [WACC]; 5y FCF grow 12.78% → 2.90% )
EPS Correlation: -42.15 | EPS CAGR: -47.24% | SUE: -4.0 | # QB: 0
Revenue Correlation: -16.36 | Revenue CAGR: 4.21% | SUE: 2.00 | # QB: 4
EPS next Quarter (2026-03-31): EPS=1.66 | Chg30d=-0.050 | Revisions Net=+4 | Analysts=10
EPS next Year (2026-12-31): EPS=7.83 | Chg30d=+0.046 | Revisions Net=+1 | Growth EPS=+25.3% | Growth Revenue=+12.8%